Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Methods of Documentation IV: Focus Charting

Methods of Documentation IV: Focus Charting

Focus Charting, also known as the focus charting system or "focus documentation," is a systematic documentation approach used in healthcare to organize patient information in medical records.
It typically involves three columns for recording information:

Methods of Documentation I: Source-Oriented Records

Methods of Documentation I: Source-Oriented Records

Source-oriented records, or SOR, are medical record-keeping organized by the data source. The SOR system was first developed in the mid-1900s to organize the growing patient data in hospitals and other healthcare facilities.
In an SOR, each discipline involved in patient care maintains a separate medical record section. This record-keeping method enables easy tracking of patient progress and ensures healthcare staff have access to up-to-date information.
Key Attributes include the following:

Groupthink

Groupthink

When in group settings, we are often influenced by the thoughts, feelings, and behaviors around us. Groupthink is another phenomenon of conformity where modification of the opinions of members in a group aligns with what they believe is the group consensus (Janis, 1972). In such situations, the group often takes action that individuals would not perform outside the group setting because groups make more extreme decisions than individuals do. Moreover, groupthink can hinder opposing trains of...

Methods of Documentation III: PIE

Methods of Documentation III: PIE

Problem-intervention-evaluation (PIE) is a systematic approach to documentation used in healthcare settings for clinical decision-making and patient care planning. It is a structured approach to organizing patient data based on problems, interventions, and evaluations. Here's a breakdown of its key features and considerations:

Fixation and Sectioning

Fixation and Sectioning

Two basic types of preparation are used to visualize specimens with a light microscope: wet mounts and fixed specimens.
The simplest type of preparation is the wet mount, in which the specimen is placed in a drop of liquid on the slide. A liquid specimen can be directly deposited on the slide using a dropper. Solid specimens, such as skin scraping, can be placed on the slide before adding a drop of liquid to prepare the wet mount. Sometimes the liquid is simply water, but stains are often added...

Lineage Commitment

Lineage Commitment

Commitment is the process whereby stem cells:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Corrigendum to "Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)": [Ann Oncol 26 (2015) 2168-2173].

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Same author

Expression of antibody-drug conjugate targets in soft tissue sarcomas.

ESMO open·2025

Same author

Acquired cutaneous pseudoxanthoma elasticum progressing after chronic liver transplant rejection.

Annales de dermatologie et de venereologie·2025

Same author

Management of Tinea Capitis in children under 10 kg : Results from a French multicentre study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025

Same author

Radiation-associated angiosarcoma of the breast: consider chemotherapy.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2025

Same author

Sudden Gastrointestinal Deaths of a Child due to a Fecaloma: a Multilevel Forensic Pathological Approach.

La Clinica terapeutica·2025

Same journal

[ONCONNECTE À L'EMPLOI, feedback after three years of a program to prepare for returning to work after cancer in Franche-Comté].

Bulletin du cancer·2026

Same journal

[Off-label use of venetoclax in myeloma].

Bulletin du cancer·2026

Same journal

[Cemiplimab - Adjuvant treatment for the cutaneous squamous cell carcinomas with high risk of relapse, operated and treated by radiotherapy].

Bulletin du cancer·2026

Same journal

Real-world outcomes and management of endometrial cancer in France from 2016 to 2021 (MOONBEAM study).

Bulletin du cancer·2026

Same journal

[Cardiotoxicity in children and adolescents with acute leukemia: Recommendations from the Leukemia Committee of the French Society of Childhood Cancer (SFCE)].

Bulletin du cancer·2026

Same journal

[Reirradiation: A new therapeutic paradigm in oncology].

Bulletin du cancer·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 12, 2026

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on: April 18, 2025

[Focus on GIST management].

M Tardieu¹, J Dômont, A Cioffi

¹Institut Gustave-Roussy, Département de médecine, 39, rue Camille-Desmoulins, 94800 Villejuif cedex, France.

Bulletin Du Cancer

|May 21, 2010

Summary

This summary is machine-generated.

Imatinib is effective for metastatic gastrointestinal stromal tumors (GIST), but resistance and optimal treatment duration remain challenges. New tyrosine-kinase inhibitors offer hope for personalized GIST therapies.

More Related Videos

Heuristic Mining of Hierarchical Genotypes and Accessory Genome Loci in Bacterial Populations

Heuristic Mining of Hierarchical Genotypes and Accessory Genome Loci in Bacterial Populations

Published on: December 7, 2021

Acquiring Fluorescence Time-lapse Movies of Budding Yeast and Analyzing Single-cell Dynamics using GRAFTS

Acquiring Fluorescence Time-lapse Movies of Budding Yeast and Analyzing Single-cell Dynamics using GRAFTS

Published on: July 18, 2013

Related Experiment Videos

Last Updated: Jun 12, 2026

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on: April 18, 2025

Heuristic Mining of Hierarchical Genotypes and Accessory Genome Loci in Bacterial Populations

Heuristic Mining of Hierarchical Genotypes and Accessory Genome Loci in Bacterial Populations

Published on: December 7, 2021

Acquiring Fluorescence Time-lapse Movies of Budding Yeast and Analyzing Single-cell Dynamics using GRAFTS

Acquiring Fluorescence Time-lapse Movies of Budding Yeast and Analyzing Single-cell Dynamics using GRAFTS

Published on: July 18, 2013

Area of Science:

Oncology
Pharmacology
Gastroenterology

Background:

Imatinib revolutionized metastatic gastrointestinal stromal tumor (GIST) treatment.
Adjuvant imatinib efficacy is proven for localized GIST, but optimal duration and relapse management are debated.
Imatinib is also used in the neoadjuvant setting to improve surgical resection quality.

Purpose of the Study:

To review current knowledge on imatinib use in GIST care.
To highlight challenges in imatinib treatment, including resistance and optimal duration.
To discuss emerging therapeutic strategies for GIST.

Main Methods:

Literature review of imatinib efficacy and resistance in GIST.
Analysis of current treatment standards in localized, neoadjuvant, and metastatic settings.
Discussion of ongoing research into novel tyrosine-kinase inhibitors.

Main Results:

Imatinib is the first-line standard for metastatic GIST, administered until progression or intolerance.
Secondary resistance to imatinib is a significant clinical issue.
Sunitinib shows efficacy as a second-line treatment.

Conclusions:

Further understanding of imatinib resistance mechanisms and pharmacokinetics is crucial.
Development of new broad-spectrum tyrosine-kinase inhibitors is promising.
Individualized therapeutic strategies are anticipated for future GIST patient care.